Reuters Health Report

Click to View in Browser 06/13/2014 Saudi MERS response hobbled by institutional failings RIYADH/LONDON (Reuters) - When Saudi Arabia announced last week it had found 113 more cases of the deadly Middle East Respiratory Syndrome (MERS), it didn't just force a rethink of the threat the virus poses, it exposed institutional failings. Public knows little about head and neck cancers: study NEW YORK (Reuters Health) - Few Americans know the signs and symptoms of head and neck cancers, a new study shows. Ackman seeks court ruling on Allergan special meeting (Reuters) - William Ackman's Pershing Square Capital Management said it had filed a lawsuit seeking confirmation that its request to hold a special shareholder meeting of Allergan Inc would not trigger Allergan's poison pill takeover defense. OncoMed halts enrollment in trials testing cancer drugs (Reuters) - OncoMed Pharmaceuticals Inc said it halted patient enrollment and dosing in early-stage trials testing two of its experimental cancer drugs, due to concerns of bone damage. Apps for gay, bisexual men tied to STI risk NEW YORK (Reuters Health) – Gay and bisexual men who use smartphone apps to meet other men for sex are at an increased risk of some sexually transmitted infections, suggests a new study. Women with breast cancer don't get enough exercise: study NEW YORK (Reuters Health) - Only one in three women living with breast cancer is meeting current physical activity guidelines, suggests a new study. More states report cases of mosquito-borne chikungunya virus TAMPA Fla. (Reuters) - A painful, mosquito-borne viral illness has surfaced across the United States, carried by recent travelers to the Caribbean where the virus is raging. U.S. teenagers smoke less, but texting while driving a concern: CDC ATLANTA (Reuters) - Fewer U.S. teenagers are smoking cigarettes, fighting or having sex, but texting while driving is prevalent among high school students, according to a survey released by the Centers for Disease Control and Prevention on Thursday. FDA panel advises against large opioid-constipation drug safety trials WASHINGTON (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended on Thursday that the agency not require large cardiovascular safety trials for a class of drugs used to treat opioid-induced chronic constipation. Weight gain differs with various antidepressants NEW YORK (Reuters Health) - People who take antidepressants tend to put on a few pounds, a new study confirms, and some of the drugs are linked to more weight gain than others. Related Video Frozen ants reveal secrets of engineering excellence Hyundai's hydrogen fuel cell car hits the road in California The latest Reuters articles on M&A, IPOs, private equity, hedge funds and regulatory updates delivered to your inbox each day. Register Today   A daily digest of breaking business news, coverage of the US economy, major corporate news and the financial markets. Register Today   » MORE NEWSLETTERS

- 3 Times Square New York, NY 10036 USA © Copyright 2010 Thomson Reuters Ensure delivery of Reuters Newsmails, add mail@nl.reuters.com to your address book. Details Subscribe to other Reuters newsletters. Unsubscribe from this newsletter. Follow us on Twitter Friend us on Facebook Forward to a friend